Equities

Nucleus Software Exports Ltd

NUCLEUS:NSI

Nucleus Software Exports Ltd

Actions
TechnologyTechnology
  • Price (INR)1,243.40
  • Today's Change69.15 / 5.89%
  • Shares traded106.28k
  • 1 Year change+4.31%
  • Beta0.7855
Data delayed at least 15 minutes, as of Jun 07 2024 11:27 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nucleus Software Exports Limited is a provider of lending and transaction banking products to the financial services industry. The Company is engaged in the business of development and marketing of software, product, and software services for business entities in the banking and financial services (BFS) vertical having its operating units located in Noida, Uttar Pradesh. It operates in seven geographical segments: India, Far East, Southeast Asia, Europe, Middle East, Africa, and Australia. Its two flagship products include FinnOne Neo and FinnAxia. FinnOne Neo suite is an end-to-end solution for lending businesses. FinnAxia suite offers an enterprise solution for the transaction banking operations of corporate banks. It provides various lending, such as FinnOne Neo retail lending, FinnOne Neo corporate lending, FinnOne Neo digital channels, and Nucleus lending analytics. Its transaction banking includes advisory services and FinnAxia cash and liquidity management.

  • Revenue in INR (TTM)8.26bn
  • Net income in INR1.92bn
  • Incorporated1989
  • Employees1.78k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
63 Moons Technologies Ltd4.72bn2.23bn15.26bn794.006.860.45596.293.2348.2848.28102.43726.450.1328--10.56--5.970.03336.530.036299.36--44.980.4408----0.001684.3562.7612.571,464.33---26.080.00
Expleo Solutions Ltd9.65bn904.41m18.04bn3.93k17.862.9514.531.8765.0765.07679.43393.781.29--3.95--12.1014.9614.7819.4799.4898.169.3711.76--40.550.068--54.4627.82-2.5120.0948.89--
Quick Heal Technologies Ltd2.92bn242.40m22.02bn1.04k92.405.0459.777.554.454.4554.2381.660.58011.872.29--4.828.655.639.6397.6696.038.3119.294.9338.08--36.174.91-1.52278.75-23.38-6.988.45
Accelya Solutions India Ltd5.06bn947.69m23.26bn1.31k24.55--18.504.6063.4863.48335.43--------3,859,004.00--26.52--34.27--99.4218.7522.21--114.58--75.2627.414.2466.337.28-0.79987.16
Saksoft Ltd7.62bn961.73m23.68bn1.97k25.984.9321.913.119.059.0571.7047.661.12--5.47--14.2014.5919.2919.23----12.6312.27--35.390.04959.5214.4316.2917.3221.410.805714.87
Network People Services Technologies Ltd-100.00bn-100.00bn25.90bn268.00------------------------------------------------112.32--336.13------
Datamatics Global Services Ltd15.50bn1.98bn28.52bn6.79k14.393.5812.221.8433.6033.60262.81134.901.13--5.58--14.3612.4916.5615.3599.8697.9112.7210.42--105.450.01413.046.226.464.8921.61-9.2637.97
Mps Ltd5.45bn1.19bn30.12bn2.21k25.326.6121.715.5270.1470.14322.06268.810.841--5.82--18.3216.3924.1820.30----21.7819.27--174.310.0098--8.838.518.779.3316.5924.57
Nucleus Software Exports Ltd.8.26bn1.92bn30.44bn1.78k15.893.9214.773.6871.5671.56308.67290.380.8314--4.85--19.2713.6426.2518.36----23.1818.96--216.680.005918.8130.2611.2949.9320.7826.766.79
Entero Healthcare Solutions Ltd39.22bn391.09m44.72bn3.18k103.862.7369.001.149.909.90952.18376.622.159.296.93--2.18--3.29--8.90--1.01--2.641.450.1708--18.85--438.40------
Data as of Jun 07 2024. Currency figures normalised to Nucleus Software Exports Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

2.87%Per cent of shares held by top holders
HolderShares% Held
WhiteOak Capital Asset Management Ltd.as of 30 Apr 2024384.08k1.44%
Dimensional Fund Advisors LPas of 09 May 2024144.47k0.54%
Acadian Asset Management LLCas of 31 Mar 2024144.44k0.54%
State Board of Administration of Florida Retirement Systemas of 30 Jun 202331.20k0.12%
Fidelity Management & Research Co. LLCas of 30 Apr 202429.91k0.11%
Dimensional Fund Advisors Ltd.as of 30 Apr 202413.37k0.05%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 202411.55k0.04%
ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 20246.65k0.03%
DFA Australia Ltd.as of 30 Apr 20242.00k0.01%
Groww Asset Management Ltd.as of 30 Apr 202452.000.00%
More ▼
Data from 31 Mar 2024 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.